作者
Jakub Adamski, Brian Godman, Gabriella Ofierska-Sujkowska, Bogusława Osińska, Harald Herholz, Kamila Wendykowska, Ott Laius, Saira Jan, Catherine Sermet, Corrine Zara, Marija Kalaba, Roland Gustafsson, Kristina Garuolienè, Alan Haycox, Silvio Garattini, Lars L Gustafsson
发表日期
2010/12
来源
BMC health services research
卷号
10
页码范围
1-16
出版商
BioMed Central
简介
Background
There has been an increase in 'risk sharing' schemes for pharmaceuticals between healthcare institutions and pharmaceutical companies in Europe in recent years as an additional approach to provide continued comprehensive and equitable healthcare. There is though confusion surrounding the terminology as well as concerns with existing schemes.
Methods
Aliterature review was undertaken to identify existing schemes supplemented with additional internal documents or web-based references known to the authors. This was combined with the extensive knowledge of health authority personnel from 14 different countries and locations involved with these schemes.
Results and discussion
A large number of 'risk sharing' schemes with pharmaceuticals are in existence incorporating both financial-based …
引用总数
学术搜索中的文章
J Adamski, B Godman, G Ofierska-Sujkowska… - BMC health services research, 2010